NOVA LTD. annual report, Q4 FY2021

Nova Ltd. Form 20-F Summary

Reporting period: Fiscal year ended December 31, 2021. This is an annual report, not a standalone fourth-quarter filing; the text does not provide clear Q4-only financial results. Financial statements are prepared under U.S. GAAP and audited by EY, which issued unqualified opinions on the financial statements and internal controls.

Business context

Nova provides metrology and process-control systems, software and services used in semiconductor manufacturing. Its portfolio includes optical, X-ray, Raman and SIMS technologies. Product sales represented 81% of 2021 revenue and services 19%. The company changed its legal name from Nova Measuring Instruments Ltd. to Nova Ltd. in July 2021.

Financial performance

MetricFY2021FY2020Change / context
Revenue$416.1 million$269.4 millionUp 54.5%
Product revenue$337.0 million$209.3 millionUp 61.0%
Service revenue$79.1 million$60.1 millionUp 31.6%
Gross profit / margin$237.4 million / 57.0%$152.9 million / 56.8%Margin up 0.2 percentage points
Operating income / margin$112.4 million / 27.0%$55.6 million / 20.6%Margin up 6.4 percentage points
Net income / margin$93.1 million / 22.4%$47.9 million / 17.8%Margin up 4.6 percentage points
Basic / diluted EPS$3.28 / $3.12$1.71 / $1.65Higher year over year
Operating cash flow$132.3 million$60.3 millionHigher mainly due to profitability

Product gross margin declined to 61.6% from 62.5%, mainly due to product mix and higher supply-chain costs. Service gross margin improved to 37.8% from 36.9%. Net financial expense was $3.1 million, versus $0.9 million of net financial income in 2020, largely reflecting convertible-note accounting expense and lower interest income. Income-tax expense was $16.2 million, with a 14.8% effective tax rate; it included approximately $3.7 million related to an Israeli tax settlement.

Liquidity, debt and capital allocation

  • At year-end, working capital was $278.6 million, versus $497.8 million in 2020. The decrease primarily reflected the convertible notes being classified as current and $137.4 million of securities being classified as non-current; management said working capital would have risen about $101.2 million excluding these classifications.
  • Cash, deposits and marketable securities totaled approximately $552.9 million, compared with $427.9 million a year earlier. Marketable securities were $199.0 million, primarily fixed-income corporate and government bonds; unrealized losses were $1.3 million.
  • The company issued $200 million of 0% convertible senior notes due October 2025. Their net carrying amount was $183.0 million, classified as current at year-end because conversion conditions were met. Management reported approximately $370 million of cash reserves net of long-term debt.
  • Capital expenditures were $4.8 million in 2021. The filing expects 2022 capital spending to exceed $20 million, mainly for manufacturing and demonstration facilities. Operating cash flow less reported property-and-equipment purchases was approximately $127.4 million.
  • On January 25, 2022, Nova completed its acquisition of ancosys for approximately $90 million in cash, including a $10 million performance-based earnout; the filing says approximately $80 million of cash was used in January. The acquisition expands the company into chemical metrology and advanced packaging.

Changes, outlook and material risks

  • Revenue rose 54.5% after increases of 19.8% in 2020 and a decline of 10.4% in 2019. Management attributed 2021 growth to stronger demand across product lines, new products, a larger installed base and higher service activity.
  • Management’s 2022 priorities include product innovation, market expansion, customer collaboration, integration of ancosys, and expanding production capacity. The filing does not provide company-specific revenue or earnings guidance. It cites Gartner forecasts for 2022 semiconductor revenue growth of 25.1%, capital-spending growth of 11.5% and wafer-fab-equipment growth of 10.7%; these are industry forecasts, not Nova guidance.
  • Management said existing cash should fund planned activities for at least the next 12 months. It expects capital spending to rise, while noting that long-term funding needs depend on business performance and acquisitions and that additional financing may not be available on acceptable terms.
  • Customer concentration remains significant: the five largest customers generated 70% of revenue, with the largest contributing 31%. Taiwan, the U.S. and China accounted for 37%, 23% and 21% of revenue, respectively.
  • Principal risks include semiconductor-cycle volatility; customer and product concentration; supply-chain constraints and higher component costs; export controls and trade tensions, particularly affecting China; competition and rapid technological change; reliance on limited suppliers and one manufacturing facility per product line; COVID-related disruption; cybersecurity and fraud; currency exposure to the NIS; and political or military instability in Israel.
  • The company disclosed fraud attempts in 2020 and 2021, including one unauthorized bank transfer; almost all funds were recovered, and no material operational or financial impact was reported. It also disclosed that U.S. export restrictions prevent its U.S. subsidiary from shipping tools, parts or services to JHICC and tools to certain SMIC sites.
  • Inventory increased to $78.7 million from $61.7 million. The auditor identified valuation of excess and obsolete inventory as a critical audit matter, emphasizing management’s sales forecasts and assumptions about future usage and demand.
  • The notes may create dilution or cash-settlement demands. A new accounting standard adopted January 1, 2022 is expected to increase potentially dilutive shares by up to 2.1 million and reduce 2022 interest expense by about $3.1 million.

Most important facts for investors to verify

  • Whether revenue growth, margins and operating cash generation are sustainable amid semiconductor-cycle changes and supply-chain pressures.
  • Customer concentration and order timing, particularly the largest customer’s 31% revenue share and the five largest customers’ 70% share.
  • Inventory quality, reserve adequacy and the effect of rising inventory on future shipments and margins.
  • Convertible-note conversion, cash-settlement and dilution scenarios, including the impact of the 2022 accounting-standard change.
  • Post-acquisition cash, earnout obligations, ancosys integration progress and expected returns against the planned increase in capital expenditures.
  • The effect of the Israeli tax settlement, future tax-benefit eligibility, currency movements and possible withholding-tax costs related to note conversions.